RIT Venture Fund
Funding rounds backed by RIT Venture Fund.
- Funding disclosed in full
- $48M
- Median round
- $48M
- Rounds in calculation
- 1
| Company | Round | Market | Investors | Announced | Details |
|---|---|---|---|---|---|
| Kanvas Biosciences Develops microbiome-based live biotherapeutics for cancer patients who do not respond to immunotherapy | $48MSeries A | BiotechUnited States |